San Francisco Mayor’s Proposal to Add $4.2M for HIV/AIDS Programs Supports ‘Getting to Zero’ Effort
Mayor Mark Farrell announced $4.2 million in additional funds for HIV/AIDS programs in San Francisco.
University of California San Francisco
Give to UCSFMayor Mark Farrell announced $4.2 million in additional funds for HIV/AIDS programs in San Francisco.
Infectious disease expert Charles Chiu explains the rise in Lyme disease cases, better diagnostic tests on the horizon and what you need to know to protect yourself from infection.
More than 100 members of the malaria research community in the Bay Area gathered to celebrate World Malaria Day on April 25 at Zuckerberg San Francisco General Hospital.
Treating young children in Sub-Saharan Africa with azithromycin, a safe, inexpensive, and widely used antibiotic, significantly reduced deaths of children under five.
A newly launched Lancet Commission on Malaria Eradication will convene experts from around the world to develop the first-ever roadmap to eradicate malaria.
Mike Reid, who has worked around the globe providing treatment for serious infectious diseases, is part of a growing effort to eliminate tuberculosis worldwide.
UCSF’s School of Medicine placed in the top five nationally in this year’s U.S. News & World Report survey of best graduate and professional schools. UCSF’s biomedical science PhD programs were among the top 10, and the School of Nursing was also highly ranked.
Sending community health workers door-to-door to look for sick kids in a rapidly urbanizing area of West Africa, and offering them free care, coincided with a dramatic drop in childhood mortality.
UCSF scientists have uncovered new mechanisms by which HIV hides in infected cells, resting in a latent state that evades the body’s immune system and preventing antiviral drugs from flushing it out.
The MEI is part of a group of partners that has been awarded a new contract by USAID to support the President’s Malaria Initiative’s Advancing the Progress of Malaria Service Delivery project in 28 countries.
A new UCSF study has shown that a cancer-killing (“oncolytic”) virus currently in clinical trials may function as a cancer vaccine.
An international team of researchers has shown that two different compounds, can safely and effectively be added to treatment regimens to block transmission of the most common form of malaria in Africa.